Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Int J Immunopathol Pharmacol ; 20(2): 401-3, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-17624254

RESUMO

Primary testicular lymphoma is an uncommon testicular tumour. We present a case of a primary non-Hodgkin lymphoma of the testis, describing its clinical and pathological features and discussing our treatment strategy. A 68-year-old man showed a firm erythematous testicular mass within the right emiscrotum. Subsequent ultrasonography demonstrated a right inferior pole testicular mass with disomogenously hypoecogenic. The patient was submitted to inguinal orchidectomy. Light microscopy demonstrated the classic appearance of a diffuse large B-cell lymphoma. The immunohistochemical study showed tumour cells intensively positive for CD45, Ki67 and CD20. No evidence of extra-testicular involvement by lymphoma was found. At 6 months, a TC-PET showed a clinical relapse in lung and abdominal lymphonodes, while clinical examination demonstrated a single, indolent and erythematous nodule in the left foot. The histologic analysis confirmed diagnosis of CD-20 positive B-cell lymphoma. The patient was treated with an anti-CD 20 monoclonal antibody (rituximab) alone every 3 weeks. After 3 months a complete response was observed in all sites of disease. The patient was free from disease at 12 months follow-up.


Assuntos
Anticorpos Monoclonais/farmacologia , Antineoplásicos/farmacologia , Linfoma de Células B/tratamento farmacológico , Linfoma Difuso de Grandes Células B/tratamento farmacológico , Neoplasias Testiculares/tratamento farmacológico , Idoso , Anticorpos Monoclonais Murinos , Humanos , Linfoma de Células B/patologia , Linfoma Difuso de Grandes Células B/patologia , Masculino , Rituximab , Neoplasias Testiculares/patologia , Neoplasias Testiculares/secundário
2.
Int J Immunopathol Pharmacol ; 20(4): 765-70, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18179749

RESUMO

We evaluated the relationship between NE expression and well-known prognostic factors and assessed whether tumor relapse after radical surgery correlates with the extent of NE differentiation. Radical prostatectomy specimens from 110 patients with clinically localized prostate cancer were assessed. Patients were followed up every three months for the first two years after surgery and six monthly for 5 additional years until failure, or for a mean of 48 months from the time of surgery for those who did not experience failure. The percentage of cells showing CgA immunoreactivity was evaluated using a visual quantitative method. Tumor staining was categorized as positive if greater than 10 percent and negative if less than 10 percent of tumor cells were stained, to ensure that only cases with significant positivity were included in the positive group. The median follow-up was 5.4 years (range 1.8 to 7.2). The median time to clinical recurrence was 7.5 years and the median time to biochemical recurrence was 2.8 years. Of 31 patients (28 percent) who experienced a PSA recurrence, 15 developed a clinical recurrence. The mean preoperative PSA level was 9 ng/ml (range 2.7 to 25). Most cases were well differentiated (Gleason score less than 7), intraprostatic (less than pT2) tumors. Immunoreactivity in >or= 10 percent of the cells was seen in 17.2 percent (n=19) of the tumor specimens. The preoperative PSA level, Gleason score, use of neoadjuvant or adjuvant therapy, lymphnode positivity were not statistically associated with NE expression. Only the primary pathologic stage appeared to be associated with CgA staining in the primary tumor (p=0.001). On the univariate analysis NE expression did not predict biochemical recurrence free survival, whereas it was associated with clinical recurrence. NE differentiation in clinically localized prostate cancer can be associated with failure after definitive surgical treatment, even if no conclusions can be drawn regarding its value as an independent prognostic factor.


Assuntos
Recidiva Local de Neoplasia/imunologia , Recidiva Local de Neoplasia/patologia , Sistemas Neurossecretores/imunologia , Neoplasias da Próstata/imunologia , Neoplasias da Próstata/patologia , Idoso , Antineoplásicos Hormonais/uso terapêutico , Biomarcadores Tumorais/análise , Quimioterapia Adjuvante , Cromogranina A/análise , Terapia Combinada , Seguimentos , Humanos , Masculino , Pessoa de Meia-Idade , Inclusão em Parafina , Fenótipo , Valor Preditivo dos Testes , Prognóstico , Prostatectomia , Neoplasias da Próstata/cirurgia , Fixação de Tecidos
3.
Pathologica ; 89(4): 432-40, 1997 Aug.
Artigo em Italiano | MEDLINE | ID: mdl-9471613

RESUMO

Invasive Aspergillosis in a child with severe granulocitopenia and endocardial fibroelastosis. A case of invasive aspergillosis in a 3-month old baby is reported. At autopsy gross examination revealed the presence of whitish nodules in the liver, spleen, kidneys and suprarenal glands. A black eschar with surrounding erythema involved the left auricle. The heart showed dilated left ventricle with porcelain-like thickening of the endocardium. The histological section of the hepatic nodular lesions showed Aspergillus colonization, vascular invasion with hyphal forms and necrotic granulomatous lesions in the other sites. Histologically, the endocardium is markedly thickened and rich in connective tissue and elastic fibres. Examination of the bone-marrow showed poor cellularity with a striking reduction of cells of the neutrophil granulocyte series. Aspergillosis may complicate the course of the child in immunocompromised state. Granulocitopenia causes an insufficient delimitation of infections and allows metastatic diffusion of fungi, through blood-vessels invasion.


Assuntos
Agranulocitose/complicações , Aspergilose/etiologia , Fibroelastose Endocárdica/complicações , Agranulocitose/patologia , Aspergilose/patologia , Medula Óssea/patologia , Dermatomicoses/complicações , Dermatomicoses/patologia , Suscetibilidade a Doenças , Fibroelastose Endocárdica/patologia , Evolução Fatal , Granuloma/patologia , Hepatomegalia/etiologia , Hepatomegalia/microbiologia , Humanos , Hospedeiro Imunocomprometido , Lactente , Pulmão/patologia , Masculino , Otite Média Supurativa/complicações , Otite Média Supurativa/microbiologia , Infecções por Pseudomonas/complicações , Infecções Respiratórias/complicações , Esplenomegalia/complicações , Ureter/anormalidades , Vísceras/microbiologia , Vísceras/patologia
4.
Am J Nephrol ; 14(4-6): 448-51, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7847484

RESUMO

Luciano Armanni (1839-1903) worked as an assistant to Schrön in Naples after graduating in medicine. He was later appointed as Professor of Histopathology, and in 1887 became a full professor. During his life he was Dissector of the Anatomic Institute of the Ospedale degli Incurabili and later director of this hospital. He founded many institutions, including the Cotugno Hospital, but died poor and suffering from diabetes mellitus and tuberculosis, contracted during a post-mortem examination. Armanni is given credit for discovering the contagious nature and specificity of the lesions due to caseous material in tuberculosis, and also the renal lesion in diabetes mellitus that now bears his name (Armanni-Ebstein lesion).


Assuntos
Nefropatias Diabéticas/história , História do Século XIX , Humanos , Itália , Patologia/história
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA